SC
GILD icon

Skylands Capital’s Gilead Sciences GILD Stock Holding History

Skylands Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-29,400
Closed -$2M – 186
2017
Q1 		$2M Buy
29,400
+2,700
+10% +$190K 0.28% 83
2016
Q4 		$1.91M Sell
26,700
-9,200
-26% -$684K 0.29% 88
2016
Q3 		$2.84M Buy
35,900
+17,500
+95% +$1.42M 0.44% 58
2016
Q2 		$1.53M Sell
18,400
-8,800
-32% -$781K 0.25% 86
2016
Q1 		$2.5M Sell
27,200
-1,700
-6% -$153K 0.4% 62
2015
Q4 		$2.92M Buy
28,900
+2,550
+10% +$265K 0.42% 61
2015
Q3 		$2.59M Sell
26,350
-1,500
-5% -$167K 0.35% 66
2015
Q2 		$3.26M Buy
27,850
+700
+3% +$76.5K 0.35% 65
2015
Q1 		$2.66M Buy
+27,150
New +$2.76M 0.27% 82

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skylands Capital's GILD Position: Q2 2017 in Review

Skylands Capital sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 29,400 shares — an estimated $2M sold.

Skylands Capital first reported a position in GILD in Q1 2015 and held it in 9 quarters. The position peaked at $3.26M in Q2 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Skylands Capital reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Skylands Capital sold 29,400 Gilead Sciences shares in Q2 2017, an estimated $2M.
  • Skylands Capital first reported a position in Gilead Sciences in Q1 2015 and held it in 9 quarters.
  • Skylands Capital's Gilead Sciences position peaked at $3.26M in Q2 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Skylands Capital's 13F filing for Q2 2017, filed 20 Jul 2017.